button bars forest bayes pooled summary circles
 
deaths (OS)

limited stage SCLC (ls-SCLC) - maintenance (M) limited stage SCLC (ls-SCLC) limited stage SCLC (ls-SCLC) - maintenance (M)

versus no additional treatment
nivolumab plus ipilimumab vs. no additional treatment 1 0.95 [0.59; 1.52], 1 RCT, I2=0%
inconclusive result

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons